Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at ...
Pfizer and Moderna say their work on their blockbuster Covid ... of free vaccines is expected to run out. Neither company provided CNBC with an update on the exact private market price of their ...
The logistics involved will become more costly and complex than when Moderna was selling directly to national governments. But the company plans on increasing the price of its vaccine to as much ...
Demand for coronavirus ... vaccine directly to consumers as opposed to doing so to governments. While Moderna will have to substantially increase the price of each shot -- to up to $130 per dose ...
Novavax Inc's head of research and development on Monday said an updated COVID-19 vaccine the company is already producing is ...
COVID vaccine ... money to increase the government's dwindling stockpile. As a result, Pfizer and Moderna were already planning their moves into the commercial market. Both have indicated that as soon ...
By Campbell Robertson Early in the pandemic, scientists began testing an old TB vaccine against the coronavirus ... in 2021 because of safety concerns. Moderna has paid $400 million to the ...
Moderna CEO Stéphane Bancel explains how technology from a promising new melanoma vaccine with Merck could help treat and defeat other diseases like lung, prostate and breast cancers. COVID-19 ...
while those on Moderna streaked ahead with a vaccine response 51 times higher than those on Johnson & Johnson. To ensure accuracy, volunteers were tested for prior COVID infection before getting ...
COVID arm is a harmless delayed skin reaction to the COVID vaccine. It happens about one week after the first or second shot of the Moderna vaccine but may also occur after Pfizer. If you didn’t ...
jabs from Pfizer-BioNTech and Moderna. But the posts shared online give a misleading impression of the research, which looked at how well different vaccines protect against all causes of death -- not ...
With an underused COVID-19 as vaccine its lone product, Novavax said earlier this year it may not be able to stay solvent and ...
